Los Angeles, CA -- (SBWIRE) -- 03/26/2019 -- Radiation therapy or radiotherapy is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor (for example, early stages of breast cancer). Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology.

North America accounted for the largest share of the global radiotherapy market in 2017, followed by Europe. The large share of the North American region is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of radiotherapy products owing to the increasing incidence of cancer. The Asia-Pacific is expected to register the highest growth rate during the forecast period. Factors such as rapidly increasing aging population, growing focus of players on emerging markets, improvements in healthcare infrastructure, and rising number of new cancer cases in this region are driving the growth of the radiotherapy market in the Asia-Pacific.

This report focuses on Radiotherapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Radiotherapy market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Get PDF of this report template: https://www.qyresearch.com/sample-form/form/984292/global-radiotherapy-industry-trends-and-forecast-to

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Varian Medical Systems

Elekta

GE Healthcare

Siemens

Ion Beam Applications

Philips

Accuray

Mevion Medical Systems

Toshiba Medical Systems

Segment by Regions

North America

Europe

China

Japan

Segment by Type

External Beam Radiotherapy Devices

Internal Beam Radiotherapy Devices

Segment by Application

Prostate Cancer

Breast Cancer

Lung Cancer

Cervical Cancer

Others

Get Full Report Now at USD 2,900: https://www.qyresearch.com/settlement/pre/5c31cd02eb53c5ba81ca8990172de6b1,0,1,Global%20Radiotherapy%20Industry%20Trends%20and%20Forecast%20to%202025

Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report

About Us: 
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.